
    
      This Study is Single arm, Single Centre trail to check the safety and efficacy of bone marrow
      derived autologous mononuclear cells(100 millions per dose )trial to be conducted for 36
      months in 100 patients ( below 15 years of age) with cerebral palsy in India. Primary outcome
      measures are improvement in walking ability and kinetic gait pattern
    
  